Search results
Found 12 matches for
The US Food and Drug Administration (FDA) has recently licensed a form of ketamine – esketamine – as a treatment for depression which is resistant to other treatments. It is administered as a nasal spray in a clinic, initially twice a week, then weekly or fortnightly. Regular doses of the drug are necessary to prevent relapse.
Understanding the causes and mechanisms of mental illness
Dopamine Glutamate Nutrition Pharmacology Schizophrenia
Basic Clinical Research – understanding the causes and mechanisms of mental illness, using experimental medicine approaches